SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-372315
Filing Date
2017-12-18
Accepted
2017-12-18 17:27:56
Documents
6
Period of Report
2017-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d513340d8k.htm 8-K 21321
2 EX-1.1 d513340dex11.htm EX-1.1 227837
3 EX-4.1 d513340dex41.htm EX-4.1 110346
4 EX-5.1 d513340dex51.htm EX-5.1 11628
5 EX-10.1 d513340dex101.htm EX-10.1 52368
6 GRAPHIC g513340dsp01.jpg GRAPHIC 3973
  Complete submission text file 0001193125-17-372315.txt   430309
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 171262278
SIC: 2834 Pharmaceutical Preparations